Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCERT: AXS-12 in Narcolepsy
NCT03881852Phase 2Completed
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reboxetine in narcolepsy, sponsored by Axsome Therapeutics, Inc.. Started Apr 2019; status: completed.
02
Drugs
reboxetine
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT03881852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03881852.